REnal TRansplant Outcomes After CARdiac Surgery (RETROCAR)

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT04979754
Collaborator
(none)
93
1
10.9
8.5

Study Details

Study Description

Brief Summary

In this retrospective study, the authors assess long term renal outcome in renal transplant recipients after cardiac surgery with cardiopulmonary bypass, and research factors associated with poor long term renal outcome.

Condition or Disease Intervention/Treatment Phase
  • Other: standard of care

Detailed Description

Post-operative mortality after cardiac surgery is increased in renal transplant recipients, compared with general population of cardiac surgery, or with kidney transplant recipients not undergoing cardiac surgery. If the survival of this specific population is now well studied, the long-term renal outcome is much less studied. Previous studies show a trend for increased risk of allograft dysfunction and need for permanent dialysis. This study proposes to compare long term renal outcome between renal transplant recipients and non-renal transplant recipients.

Study Design

Study Type:
Observational
Actual Enrollment :
93 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Long-term Renal Outcome After Cardiac Surgery : Impact of Previous Renal Transplantation
Actual Study Start Date :
Nov 1, 2020
Actual Primary Completion Date :
Aug 31, 2021
Actual Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
RENAL TRANSPLANT RECIPIENTS

All patients with previous renal transplantation undergoing cardiac surgery with cardiopulmonary bypass

Other: standard of care
retrospective study : standard of care

NON RENAL TRANSPLANT RECIPIENTS

All patients without previous renal transplantation undergoing cardiac surgery with cardiopulmonary bypass

Other: standard of care
retrospective study : standard of care

Outcome Measures

Primary Outcome Measures

  1. Long-term renal outcome [12 months after surgery]

    Proportion of patients meeting a composite criterion : death or permanent dialysis or doubling the baseline serum creatinine value

Secondary Outcome Measures

  1. Glomerular Filtration Rate (GFR) [30 days after surgery]

    Glomerular Filtration Rate (GFR) calculated with CKD-EPI formula

  2. Glomerular Filtration Rate (GFR) [12 months after surgery]

    Glomerular Filtration Rate (GFR) calculated with CKD-EPI formula

  3. Vital status [12 months after surgery]

    Mortality after surgery

  4. Major Adverse Kidney Events [Up to 12 months after surgery]

    Major Adverse Kidney Events defined by new receipt of Renal replacement therapy (RRT), or Acute Kidney Injury (AKI) episodes with persistent renal dysfunction and final serum creatinine value before hospital discharge ≥ 200 % of the baseline serum creatinine

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria for Renal Transplant Recipients group:
  • Previous renal transplantation

  • Who underwent cardiac surgery with CPB

Inclusion Criteria for Non Renal Transplant Récipients group:
  • No previous renal transplantation

  • Who underwent cardiac surgery with CPB

  • Apparied with Renal Transplant récipients with the 5 following criteria : age, sex, previous diagnosis of diabete, type of cardiac surgery (isolated coronary artery bypass graft, valvular surgery, aorta surgery, combined surgery), best glomerular filtration rate with CKD-EPI formula at +/- 15 ml/min, in the 3 pre-operative months

Exclusion Criteria:
  • Patients requiring mechanical circulatory support (Extracorporeal Membrane Oxygenation)

  • Pre-operative permanent dialysis

  • Aorta dissection extended to renal arteries

  • Non-elective surgery for infective endocarditis

  • Previous hepatic, pancreatic or cardiac transplantation

  • Death in the 30 first days after cardiac surgery

  • Patient not meeting the inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bordeaux University Hospital Pessac France 33604

Sponsors and Collaborators

  • University Hospital, Bordeaux

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alexandre Ouattara, MD, PhD, University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT04979754
Other Study ID Numbers:
  • SAR Sud study one
First Posted:
Jul 28, 2021
Last Update Posted:
Dec 9, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alexandre Ouattara, MD, PhD, University Hospital, Bordeaux

Study Results

No Results Posted as of Dec 9, 2021